Parkinson's Disease Costs Surge to $82.2 Billion in 2024, Decade Ahead of Projections
Event summary
- Total annual costs of Parkinson's disease in the U.S. reached $82.2 billion in 2024, surpassing the $79 billion projected for 2037.
- Indirect and non-medical costs accounted for $58.4 billion, including lost income, disability, and unpaid caregiving.
- Federal programs spent over $25 billion in 2024 on care for Parkinson's and related conditions.
- Approximately 1.2 million people in the U.S. live with Parkinson's disease or atypical parkinsonisms.
- Without intervention, annual costs are expected to exceed $112 billion by 2045.
The big picture
The escalating economic burden of Parkinson's disease highlights the urgent need for increased federal research funding and policy interventions. With costs surpassing projections by over a decade, the financial strain on patients, families, and federal programs underscores the strategic importance of accelerating research and treatment advancements. The broader implications include potential shifts in healthcare policy and increased investment in neurodegenerative disease research.
What we're watching
- Federal Funding
- Whether increased federal research funding at the NIH will be allocated to address the growing economic burden of Parkinson's disease.
- Research Breakthroughs
- The pace at which disease-modifying breakthroughs can be achieved to ease the financial strain on patients and families.
- Policy Advocacy
- How the Parkinson's Policy Forum will influence legislative action on environmental risk factors and the implementation of the National Parkinson's Project.